Loading....
Todays Question - health
some researchers suggest that aspirin’s ability to disrupt platelets could help the immune system target and destroy cancer cells before they spread. evidence from animal studies indicates that it might be most effective in early-stage cancers. additional clinical trials are underway to confirm whether this benefit translates to a broader range of patients. on the other hand, experts caution against people rushing to take aspirin without medical guidance. it carries risks of internal bleeding and strokes, so doctors must weigh individual patient factors. it also remains uncertain if all forms of cancer respond similarly to aspirin. until trials conclusively identify who is likely to benefit most, many clinicians advise discussing any aspirin use with a healthcare professional.
aspirin, cancer, metastasis, immunity